These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32751615)

  • 1. A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era.
    Napoli PE; Mangoni L; Gentile P; Braghiroli M; Fossarello M
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
    de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
    J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
    Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y
    Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic Manifestations of COVID-19: A Retrospective Study on Prevalence, Characteristics, and Clinical Implications.
    Patel M; Gandhi R; Satapara N; Babaria DL; Vala RB; Murugan Y
    Cureus; 2024 Apr; 16(4):e59177. PubMed ID: 38807797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular manifestations of COVID-19 in pediatric patients.
    Ichhpujani P; Singh RB; Dhillon HK; Kumar S
    Ther Adv Ophthalmol; 2023; 15():25158414221149916. PubMed ID: 36938488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic Presentations and Manifestations of COVID-19: A Systematic Review of Global Observations.
    Pace JL; Richard D; Khachik A; Mistry M; Singh G; Mostaghni N; Yazdanmehr S
    Cureus; 2023 Jun; 15(6):e40695. PubMed ID: 37485114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery.
    Li X; Peng T
    Front Pharmacol; 2021; 12():660710. PubMed ID: 34017257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.
    Felfeli T; Kasloff SB; Krishnan J; El-Defrawy SR; Mazzulli T; Cutts TA
    BMJ Open Ophthalmol; 2021; 6(1):e000765. PubMed ID: 34192157
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibiting Extracellular Vesicle Trafficking as Antiviral Approach to Corona Virus Disease 2019 Infection.
    Urciuoli E; Peruzzi B
    Front Pharmacol; 2020; 11():580505. PubMed ID: 33013421
    [No Abstract]   [Full Text] [Related]  

  • 10. Conjunctivitis in Novel Coronavirus Disease (COVID-19).
    Madan S; Beri S
    Indian J Occup Environ Med; 2020; 24(2):129-130. PubMed ID: 33281386
    [No Abstract]   [Full Text] [Related]  

  • 11. Response: Comment on "Update on coronavirus disease 2019: Ophthalmic manifestations and adverse reactions to vaccination".
    Lin T
    Asia Pac J Ophthalmol (Phila); 2024 Jul; ():100083. PubMed ID: 39038653
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on "Update on coronavirus disease 2019: Ophthalmic manifestations and adverse reactions to vaccination".
    Wiwanitkit V; Daungsupawong H
    Asia Pac J Ophthalmol (Phila); 2024 Jun; ():100079. PubMed ID: 38844078
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophysiology in the Era of Coronavirus Disease 2019.
    Kanthasamy V; Schilling RJ
    Arrhythm Electrophysiol Rev; 2020 Nov; 9(3):167-170. PubMed ID: 33240513
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye.
    Bertoli F; Veritti D; Danese C; Samassa F; Sarao V; Rassu N; Gambato T; Lanzetta P
    J Ophthalmol; 2020; 2020():4827304. PubMed ID: 32963819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Ocular Tissue in SARS-CoV-2 Transmission.
    Peng M; Dai J; Sugali CK; Rayana NP; Mao W
    Clin Ophthalmol; 2020; 14():3017-3024. PubMed ID: 33061288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Surface Impairment After Coronavirus Disease 2019: A Cohort Study.
    Gambini G; Savastano MC; Savastano A; De Vico U; Crincoli E; Cozzupoli GM; Culiersi C; Rizzo S
    Cornea; 2021 Apr; 40(4):477-483. PubMed ID: 33214412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effects of Lactoferrin in Ocular Diseases: From Dry Eye Disease to Infections.
    Vagge A; Senni C; Bernabei F; Pellegrini M; Scorcia V; Traverso CE; Giannaccare G
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of Ocular Transmission of SARS-CoV-2: A Review.
    Barnett BP; Wahlin K; Krawczyk M; Spencer D; Welsbie D; Afshari N; Chao D
    Vision (Basel); 2020 Sep; 4(3):. PubMed ID: 32883010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of dry eye symptoms of medical staffs working in hospital during 2019 novel coronavirus outbreak.
    Long Y; Wang X; Tong Q; Xia J; Shen Y
    Medicine (Baltimore); 2020 Aug; 99(35):e21699. PubMed ID: 32871886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding.
    Ocansey S; Abu EK; Abraham CH; Owusu-Ansah A; Boadi-Kusi SB; Ilechie AA; Acheampong DO
    Ocul Immunol Inflamm; 2020 Nov; 28(8):1269-1279. PubMed ID: 32870054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.